3,4-DIMETHOXYBENZOYL CHLORIDE | CAS:3535-37-3

We serve 3,4-DIMETHOXYBENZOYL CHLORIDE CAS:3535-37-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3,4-DIMETHOXYBENZOYL CHLORIDE

Chemical Name:3,4-DIMETHOXYBENZOYL CHLORIDE
CAS.NO:3535-37-3
Synonyms:3,4-DIMETHOXYBENZOYL CHLORIDE
3,4-dimethoxyphenylcarboxylic chloride
3,4-dimethoxybenzoic chloride
3,4-Dimethoxybenzoylchloride
3,4-dimethoxybenzoic acid chloride
veratroyl chloride
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 298.2±20.0 °C at 760 mmHg
Melting Point 70-73 °C(lit.)
Molecular Formula C9H9ClO3
Molecular Weight 200.619
Flash Point 129.2±20.8 °C
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.521
 
Specification:
Appearance:White to off-white crystalline powder
Assay(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Itopride(CAS:122898-67-3).



Contact us for information like 3,4-DIMETHOXYBENZOYL CHLORIDE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,veratroyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,veratroyl chloride Use and application,3,4-dimethoxyphenylcarboxylic chloride technical grade,usp/ep/jp grade.


Related News: “Traditional medicine is a treasure of Chinese civilization embodying the wisdom of the nation and its people,” Xi said at the meeting in Beijing.2-Fluoro-6-methylaniline manufacturer The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.N-BUTYLTRIMETHOXYSILANE supplier If the government does not close the border and heed their other demands by 9 p.m., union members handling emergency services would also strike, the union said.2-Bromo-6-nitrophenol vendor “This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.But they’ll be subject to up to 14 days of mandatory quarantine once they’re back in the US.